PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
August 5, 2026Current Treatment Options in PediatricsOpen Access

Modern Management of Neurogenic Bladder

View Full Paper
Ask AI
Bookmark
Share

Authors

VRVijay K. RingsDCDouglass B. Clayton

Discussion

Loading...

Member takes

Overview

Review highlights advances in management of neurogenic bladder in pediatric patients, suggesting improved outcomes.

Key Points

  • This review aims to discuss modern strategies for managing pediatric neurogenic bladder, focusing on spina bifida.
  • Overview of changing treatment paradigms incorporating early diagnosis and pharmacotherapy.
  • Emphasis on bladder preservation and urinary tract health monitoring.
  • Consideration of pharmacologic therapies and structured management guidelines.
  • Increased reliance on medical management as the first-line therapy.
  • Anticholinergic agents are the primary treatment, with beta-3 adrenergic agonists used as adjuncts.
  • Intradetrusor onabotulinumtoxinA shows improved bladder compliance and continence outcomes.

Cite This Study

Rings et al. (2026) studied this question.

synapsesocial.com/papers/6a72e841226790f370657fa9https://doi.org/10.1007/s40746-026-00382-8
View Full Paper
Ask AI
Bookmark
Share